A seamless, self-expanding implantable device having a low profile is disclosed along with methods of making and using the same. The implantable device includes a frame cut out of a single piece of material that is formed into a three-dimensional shape. The implantable device may comprise an embolic filter, stent, or other implantable structure. The present invention also allows complicated frame structures to be easily formed from planar sheets of starting material, such as through laser cutting, stamping, photo-etching, or other cutting techniques.
|
1. An embolic protection filter, comprising:
a unibody and seamless frame that includes a support member and a plurality of struts that extend in a generally proximal direction from the support member to a connecting member that is coupled to a guide wire;
a filter media that includes a base portion and a closed tapered portion, the base portion defining an open proximal end of the filter media and extending in a generally distal direction from the support member, wherein the closed tapered portion of the filter media is inverted toward the open proximal end of the filter media, and wherein an end region of the closed tapered portion of the filter media is located proximal of the open proximal end of the filter media.
20. A thrombectomy device, comprising:
a unibody and seamless frame that includes a support member and a plurality of struts that extend in a generally proximal direction from the support member to a connecting member that is coupled to a guide wire;
a filter media that extends in a generally distal direction from the support member, the filter media being adapted to permit blood to pass through the filter media and to capture embolic debris carried by the blood;
wherein the support member includes a sharp edge that is adapted to shear an intraluminal thrombus as the thrombectomy device is pulled through an area of a blood vessel that includes the intraluminal thrombus, and wherein the filter media is adapted to capture sheared debris from the intraluminal thrombus.
13. A method of removing embolic debris from a vessel of a patient, comprising:
deploying a thrombectomy device distal of a thrombus in the vessel of the patient, the thrombectomy device comprising a filter media and a unibody and seamless frame that includes a support member and a plurality of struts that extend in a generally proximal direction from the support member to a connecting member that is coupled to a guide wire, wherein the filter media extends in a generally distal direction from the support member;
providing a proximally directed force at the guide wire to cause the frame of the thrombectomy device to be pulled at least partially through the thrombus, wherein the support member is adapted to shear thrombatic material of the thrombus as the frame of the thrombectomy device is pulled at least partially through the thrombus, and wherein the filter media is adapted to capture the thrombatic material.
2. The embolic protection filter of
3. The embolic protection filter of
4. The embolic protection filter of
5. The embolic protection filter of
6. The embolic protection filter of
7. The embolic protection filter of
9. The embolic protection filter of
10. The embolic protection filter of
11. The embolic protection filter of
12. The embolic protection filter of
14. The method of
16. The method of
17. The method of
18. The method of
19. The method of
21. The thrombectomy device of
22. The thrombectomy device of
23. The thrombectomy device of
24. The thrombectomy device of
25. The thrombectomy device of
|
This application is a continuation of U.S. patent application Ser. No. 10/907,987, filed Apr. 22, 2005 (now U.S. Pat. No. 8,337,520 issued on Dec. 25, 2012), which is a divisional of U.S. patent application Ser. No. 10/113,724, filed Apr. 1, 2002, now abandoned. This application is also a continuation of U.S. patent application Ser. No. 10/907,975, filed Apr. 22, 2005 (now U.S. Pat. No. 8,313,503 issued Nov. 20, 2012), which is a divisional of U.S. patent application Ser. No. 10/113,724 filed Apr. 1, 2002, now abandoned. The disclosures of the prior applications are considered part of this application and are hereby incorporated by reference in their entirety for all purposes.
The present invention relates to seamless endoluminal devices including frame patterns for filters, their manufacture and use in the filtration and/or removal of embolic matter from fluids flowing in tubular body lumens including, but not limited to: blood flow in arteries and veins; airflow within the respiratory tract; and the flow of urine in the urinary tract. The seamless filter of the present invention may be self-expanding, is deployable via a guidewire-based system and has a low profile.
Embolic protection is a concept of growing clinical importance directed at reducing the risk of embolic complications associated with interventional (i.e., transcatheter) and surgical procedures. In therapeutic vascular procedures, liberation of embolic debris (e.g., thrombus, clot, atheromatous plaque, etc.) can obstruct perfusion of the downstream vasculature, resulting in cellular ischemia and/or death. The therapeutic vascular procedures most commonly associated with adverse embolic complications include: carotid angioplasty with or without adjunctive stent placement and revascularization of degenerated saphenous vein grafts. Additionally, percutaneous transluminal coronary angioplasty (PTCA) with or without adjunctive stent placement, surgical coronary artery by-pass grafting, percutaneous renal artery revascularization, and endovascular aortic aneurysm repair have also been associated with complications attributable to atheromatous embolization. Intra-operative capture and removal of embolic debris, consequently, may improve patient outcomes by reducing the incidence of embolic complications.
The treatment of stenoses of the carotid bifurcation provides a good example of the emerging role of adjuvant embolic protection. Cerebrovascular stroke is a principle source of disability among adults, and is typically associated with stenoses of the carotid bifurcation. The current incidence of cerebrovascular stroke in Europe and the United States is about 200 per 100,000 population per annum (Bamford, Oxfordshire community stroke project. Incidence of stroke in Oxfordshire. First year's experience of a community stroke register. BMJ 287: 713-717, 1983; Robins, The national survey of stroke: the National Institute of Neurological and Communicative Disorders and Stroke. Office of Biometry and Field Studies Report. Chapter 4. Incidence. Stroke 12 (Suppl. 1): 1-57, 1981). Approximately half of the patients suffering ischemic stroke have carotid artery stenoses (Hankey, Investigation and imaging strategies in acute stroke and TIAs. Hospital Update 107-124, 1992). Controlled studies have shown that the surgical procedure carotid endarterectomy (CEA) can reduce the incidence of stroke in patients compared to medical therapy with minimal perioperative complications (<6% for symptomatic patients with stenoses >70% [NASCET, Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenoses. NEJM 325: 445-453, 1991] and <3% for asymptomatic patients with 60% stenoses [ACAS, Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273: 1321-1461, 1995]). These results provide convincing evidence of the benefit of treating carotid stenoses. Surgery, however, does have several limitations, including: increased mortality in patients with significant coronary disease (18%), restriction to the cervical portion of the extra-cranial vasculature, a predeliction for cranial palsies (7.6%-27%), and restenosis (5%-19%; Yadav, Elective stenting of the extracranial carotid arteries. Circulation 95: 376-381, 1997).
Carotid angioplasty and stenting have been advocated as potential alternatives to CEA. Percutaneous techniques have the potential to be less traumatic, less expensive, viable in the non-cervical extracranial vasculature, and amenable to patients whom might otherwise be inoperable (Yadav, Elective stenting of the extracranial carotid arteries. Circulation 95: 376-381, 1997). Despite the potential benefits of this approach, emboli liberated during trans-catheter carotid intervention can place the patient at risk of stroke. Emboli can be generated during initial accessing of the lesion, balloon pre-dilatation of the stenosis, and/or during stent deployment. Additionally, prolapse of atheromatous material through the interstices of the stent can embolize after the completion of the procedure.
The fear of dislodging an embolus from an atherosclerotic plaque has tempered the application of angioplasty and endovascular stenting to the supraaortic arteries and, particularly, to the carotid bifurcation (Theron, New triple coaxial catheter system for carotid angioplasty with cerebral protection. AJNR 11: 869-874, 1990). This concern is warranted due to the significant morbidity and/or mortality that such an event might produce. While the incidence of stroke may be at an acceptable level for the highly skilled practitioner, it is likely to increase as the procedure is performed by less experienced clinicians.
Embolic protection devices typically act as an intervening barrier between the source of the clot or plaque and the downstream vasculature. In order to address the issue of distal embolization, numerous apparatus have been developed and numerous methods of embolic protection have been used adjunctively with percutaneous interventional procedures. These techniques, although varied, have a number of desirable features including: intraluminal delivery, flexibility, trackability, small delivery profile to allow crossing of stenotic lesions, dimensional compatibility with conventional interventional implements, ability to minimize flow perturbations, thromboresistance, conformability of the barrier to the entire luminal cross-section (even if irregular), and a means of safely removing the embolic filter and trapped particulates.
For example, occlusion balloon techniques have been taught by the prior art and involve devices in which blood flow to the vasculature distal to the lesion is blocked by the inflation of an occlusive balloon positioned downstream to the site of intervention. Following therapy, the intraluminal compartment between the lesion site and the occlusion balloon is aspirated to evacuate any thrombus or atheromatous debris that may have been liberated during the interventional procedure. These techniques are described in Theron, New triple coaxial catheter system for carotid angioplasty with cerebral protection. AJNR 11: 869-874, 1990, and Theron, Carotid artery stenosis: Treatment with protected balloon angioplasty and stent placement. Radiology 201: 627-636, 1996, and are commercially embodied in the PercuSurge Guardwire Plus™ Temporary Occlusion and Aspiration System (Medtronic AVE). The principle drawback of occlusion balloon techniques stem from the fact that during actuation distal blood flow is completely inhibited, which can result in ischemic pain, distal stasis/thrombosis, and difficulties with fluoroscopic visualization due to contrast wash-out through the treated vascular segment.
Another prior system combines a therapeutic catheter (e.g., angioplasty balloon) and integral distal embolic filter. By incorporating a porous filter or embolus barrier at the distal end of a catheter, such as an angioplasty balloon catheter, particulates dislodged during an interventional procedure can be trapped and removed by the same therapeutic device responsible for the embolization. One known device includes a collapsible filter device positioned distal to a dilating balloon on the end of the balloon catheter. The filter comprises a plurality of resilient ribs secured to the circumference of the catheter that extend axially toward the dilating balloon. Filter material is secured to and between the ribs. The filter deploys as a filter balloon is inflated to form a cup-shaped trap. The filter, however, does not necessarily seal around the interior vessel wall. Thus, particles can pass between the filter and the vessel wall. The device also presents a large profile during positioning and is difficult to construct.
The prior art has also provided systems that combine a guidewire and an embolic filter. The filters are incorporated directly into the distal end of a guidewire system for intravascular blood filtration. Given the current trends in both surgical and interventional practice, these devices are potentially the most versatile in their potential applications. These systems are typified by a filter frame that is attached to a guidewire that mechanically supports a porous filter element. The filter frame may include radially oriented struts, one or more circular hoops, or a pre-shaped basket configuration that deploys in the vessel. The filter element typically includes a polymeric mesh net, which is attached in whole or in part to the filter frame and/or guidewire. In operation, blood flowing through the vessel is forced through the mesh filter element thereby capturing embolic material in the filter.
Early devices of this type include a removable intravascular filter mounted on a hollow guidewire for entrapping and retaining emboli. The filter is deployable by manipulation of an actuating wire that extends from the filter into and through the hollow tube and out the proximal end. During positioning within a vessel, the filter material is not fully constrained so that, as the device is positioned through and past a clot, the filter material can potentially snag clot material creating freely floating emboli, prior to deployment.
In another prior art system an emboli capture device is mounted on the distal end of a guidewire. The filter material is coupled to a distal portion of the guidewire and is expanded across the lumen of a vessel by a fluid activated expandable member in communication with a lumen running the length of the guidewire. During positioning, as the device is passed through and beyond the clot, filter material may interact with the clot to produce emboli. This device may also be difficult to manufacture.
Another prior art device is adapted for deployment in a body vessel for collecting floating debris and emboli in a filter that includes a collapsible proximally tapered frame for operably supporting the filter between a collapsed insertion profile and an expanded deployment profile. The tapered collapsible frame includes a mouth that is sized to extend to the walls of the body vessel in the expanded deployed profile to seal the filter relative to the body vessel for collecting debris floating in the body vessel.
A further example of an embolic filter system involves a filter material fixed to cables or spines of a central guidewire. A movable core or fibers inside the guidewire can be utilized to transition the cables or spines from approximately parallel to the guidewire to approximately perpendicular to the guidewire. The filter, however, may not seal around the interior vessel wall. Thus, particles can pass between the filter and the entire vessel wall. This umbrella-type device is shallow when deployed so that, as it is being closed for removal, particles have the potential to escape.
Other disadvantages associated with the predicate devices are that the steerability of the guidewire may be altered as compared to the conventional guidewires due to the presence and size of the filter. The guidewire, for example, may bend, kink, and/or loop around in the vessel, making insertion of the filter through a complex vascular lesion difficult. Also, delivery of such devices in a low-profile pre-deployment configuration can be difficult. Further, some devices include complex and cumbersome actuation mechanisms. Also, retrieving such capture devices after they have captured emboli may be difficult. Further, when deployed in curved segments, the interaction of the guidewire and/or tether elements can deform the filter frame in such a way as to limit apposition to the host vessel wall, thereby allowing potential channels for passage of embolic debris. Also, the filter media of the prior art maintains a pore diameter of approximately 80 to 120 microns. It is desirable to minimize the pore size without adversely perturbing blood flow or being prone to clogging.
Current filter designs suffer from numerous disadvantages due to their construction. A typical wire filter is formed by manipulating multiple wires together through welding or some other form of attachment. After the wire frame is constructed, it is formed into the desired shape and a filter element is affixed onto the wire cage. A typical wire frame constructed in this manner is subject to a limited range of manipulation after the wires are adhered, since the welds or attachment areas are at an increased risk of failure due to the physical constraints of the welds themselves. A wire pair is more inclined to fracture at the weakest point, typically, a wire frame, composed of numerous wire pairs, will separate at the weld before separating in the length of the wire. Additionally, the welding of metal involves the application of increased heat to join a wire pair and a risk exists of the mesh, formed by the pairs, dripping or otherwise malforming due to the proclivity of metal to run before cooling.
A further disadvantage to a typical wire filter is that the filter element is difficult to apply to the frame since the filter is normally applied as a sock, tube, or other such shape. The typical wire frame is formed by welding and bending into the desired shape. The filter is then affixed onto the shaped wire frame by pulling the formed filter over the shaped wire frame. An additional problem evident in this construction is that the filter element could be abraded by a protrusion formed by a weld in a wire pair. Such an abrasion could form a weakness or a tear in the filter and undermine its desired functionality.
Simple and safe blood filtering and guidewire systems that can be temporarily placed in the vasculature to prevent distal embolization during endovascular procedures, and that can be used to introduce and/or exchange various instruments to a region of interest without compromising the position of the filter or guidewire, are required. Existing guidewire-based embolic filtering devices are inadequate for these and other purposes. The present apparatus, in contrast, provides a novel means of providing these and other functions, and has the further benefit of being easier to manufacture than the devices of the prior art.
The present invention relates to seamless implantable devices, filters, methods of manufacture, systems for deployment and methods of use.
One aspect of the present invention is to provide a low profile filter formed from a single piece of material.
Another aspect of the present invention is to provide a self-expanding filter that is seamless.
A further aspect of the present invention is to provide an integral self-expanding filter frame that is seamless.
A still further object of the present invention is to provide a seamless, low-profile filter that minimally perturbs flow.
A further aspect of the present invention to provide a low profile, seamless filter that is readily connected to the guidewire of a endoluminal deployment system.
A further aspect of the invention is to provide a filter apparatus, which maintains vessel wall apposition and a maximally open mouth when deployed in tortuous anatomy.
A further aspect of the invention is to provide a filter frame, which can be rendered sufficiently radiopaque.
A further aspect of the present invention is to provide filters which have increased capture efficiency and are capable of providing drug delivery.
A further aspect according to the present invention includes providing a seamless frame having a proximal end, a longitudinal axis, a seamless support member circumscribing the axis and distally spaced from the proximal end, and at least one attachment strut, and optionally at least one filter strut seamlessly extending from the support member.
Another aspect of the present invention is to provide a seamless frame having a proximal end, a longitudinal axis, a seamless support member circumscribing the axis and distally spaced from the proximal end, and at least one attachment strut, optionally at least one filter strut seamlessly extending from the support member, and at least one or more filter media layers.
Another aspect of the present invention is to provide implantable devices that may be configured as detachable devices designed for permanent implantation and/or subsequent retrieval and are used for: temporary vascular occluders; exclusion of bleeding varices or aneurysmal vascular segments; a stent, or similar means of providing structural support to an endoluminal cavity; a thrombectomy/atherectomy instrument; an implantable prosthetic vascular conduit wherein the proximal filter frame functions as an anchoring stent, and the distal filter is configured into an open-ended, tubular configuration (similar to a windsock) allowing endoluminal lining of a vascular segment with a biocompatible liner.
An aspect of the present invention is to provide seamless implantable devices formed from a single piece of material.
Another aspect of the present invention is to provide seamless implantable devices that have regions of articulation and/or radiopaque markers.
A further aspect of the present invention to provide seamless implantable devices that include radiopaque markers.
A still further aspect of the present invention is to provide stents or similar means of providing structural support to an endoluminal cavity, and which may include regions of articulation and/or radiopaque markers.
A further aspect of the present invention to provide a seamless stent, or similar means of providing structural support to an endoluminal cavity.
A still further aspect of the present invention is to provide a delivery system for the inventive seamless devices, stents, occluders, filters and its use. These and other features and aspects of the invention will become more apparent in view of the following detailed description, non-limiting examples, appended claims and drawings.
As used herein the following terms are defined as followed:
The term “proximal” is defined as the location closest to the catheter hub and “distal” is the location most distant from the catheter hub. With respect to the inventive three-dimensional uni-body frame, the term “proximal” is the frame end attached to the guidewire or the frame side through which debris enters to be collected by an associated filter.
The term “uni-body” refers to a frame pattern formed from a single piece of material and therefore considered “seamless.”
Terms such as unitary, integral, one-piece are synonymous with “uni-body” and also refer to a frame pattern that is formed from a single or common piece of material.
Filament, wire or ribbon are alternate terms used to describe the portions/sections of pattern material that remain after etching a planar precursor frame material and form the attachment struts, the support struts, the filter/filter support struts that extend in the longitudinal, circumferential, or any other direction necessary to define a frame pattern.
A desired pattern is formed on sheet material 110, as in the case of
Radial sides 125, 130 and arcuate side 135 circumscribe the wedges 120. Slits 145 are formed and center section 150 is removed by any suitable cutting technique. After the slits 145 are formed, and wedges 120 and center section 150 removed, flashing 140 is removed (such as by trimming with fine scissors or diagonal cutters), leaving the desired skeletal two-dimensional filter frame/pattern 115, shown in
Skeletal frame 115 includes attachment struts 155 with proximal ends 165 that are to be fixed or attached to proximal connecting member 170 of
The planar, two-dimensional frame pattern of
Although the above embodiments show a single support member 156A, 256A, 356A, 456A, 556A, 656A, 756A, 956A, etc., it is clearly within the scope of the invention to have a plurality of longitudinally spaced support members, i.e., members that circumscribe the longitudinal axis of the frame, that are seamlessly interconnected with one another via struts or articulation segments, as in
As shown in
Instead of using the filter-in-filter design of
As shown in
As shown in
An articulation segment of the tether elements or struts is a desirable feature in that it allows adequate vessel wall apposition of the filter frame when the filter device is deployed in a curved segment of anatomy. In a curved segment, the tether element articulates and deflects to adjust for a non-linear deployment situation (See
The articulation segments, though described with respect to the various frame patterns can be incorporated into any of the endovascular devices described herein. An articulation segment is a localized region that provides enhanced longitudinal flexibility. A localized region may have a cross-sectional area that is the same as the remaining part a strut, but differs in geometry. Alternatively, the localized region could have the same geometry but a different cross-sectional area, or both the cross-sectional area and geometry of the localized region differ from the remaining part of the strut. An endovascular stent can have articulation segments in any of the interconnected struts of
A radially-symmetric geometrical pattern comprising interconnected struts forming closed polygonal shaped cells was chemically etched from a sheet of Nitinol (NiTi) to produce a skeletal filter frame. The etching, preferably photoetching of Nitinol (Kemac Technologies, Irwindale, Calif.) is continued to achieve a desirable material thickness, to optimize the moment of inertia of the struts and to polish the surface finish.
This filter frame is then subjected to a thermal treatment to set the phase transition temperature of the NiTi to approximately 37° C. by heating the filter frame to a temperature of about 450° C. for about 10 minutes in an air convection oven (Carbolite Corporation, Sheffield, England) followed by a rapid quench in ambient temperature water.
The NiTi filter frame was then laminated between two (2) layers of an adhesive-coated porous polymer. The layers were positioned with the adhesive sides facing toward each other, and facing toward the NiTi. The adhesive was used to adhere the layers of film together as well as to the NiTi wire framework. A sacrificial porous polymer cushion material was used on each side of the device during this lamination procedure to provide compliance of the surface during compression. This compliance allows the earlier mentioned porous polymer membrane to conform to the wire shape. The composite sub-assembly which included cushion, porous polymer/adhesive laminate, NiTi, adhesive/porous polymer laminate, and cushion layers was then compressed in a SST fixture and heat treated at 320° C. for 45 minutes in an air convection oven (Grieve Oven, The Grieve Corporation, Round Lake, Ill.).
Once the ‘sandwiched’ device was removed from the heat source and allowed to cool, the sacrificial cushion material was peeled away from each side of the device and the NiTi wires were disengaged from the fixture. A circular shape of approximately 0.625″ in diameter was trimmed into the porous polymer using a 20-watt carbon dioxide laser. The remainder of porous polymer was trimmed from the wire frame by hand and discarded.
Following the laser trimming operation (which can also be used to create the necessary pores in the filter media), the radially-oriented arms (struts) of the device were folded up and back on themselves to achieve a hollow, three dimensional, semi-conical shape. To maintain the device in this configuration, the NiTi struts were inserted into a SST tube. This tube measured approximately 0.05″ in length×0.035″ outer diameter×0.025″ inner diameter. This tube and indwelling NiTi wires were then crimped to a 0.014″ diameter guidewire to provide a guidewire based endoluminal embolic protection device. The device resembled a three dimensional “whisk” shape with a pleated porous polymer filter element attached to it.
The resulting pleats are designed to increase filter media surface area over the generally conical shapes found in the prior art. This increase in surface area also allows for a shorter filter length which enhances deliverability of the device by a) decreasing friction in the delivery catheter and b) improving device overall flexibility.
A 1.3 mm Nitinol tube with a wall thickness of approx 0.1 mm (obtained from Nitinol Devices and Components, Fremenot, Calif.) was laser cut (Laserage Technologies Inc, Waukegan, Ill.) to a single, undulating 6 apex ring geometry with integral tethers. This frame was then lightly grit blasted at 40 psi with 20 micron silicon carbide media in a grit blasting machine made by Comco Inc, Burbank, Calif. The ring with integral tethers was then gently pushed up a tapered mandrel until it achieved a functional size of approx. 6 mm. The ring, tethers and mandrel were then subjected to a thermal treatment to set the phase transition temperature of the NiTi to approximately 37° C. in an air convection oven (Carbolite Corporation, Sheffield, England) One skilled in the art will realize that variances in the geometry, metallurgy, thickness and heat treating of the filter frame can all be varied to create alternate embodiments with varying desirable properties. The ring and tethers (now at functional size) were then lightly coated with an fluorinated ethylene propylene (FEP) powder (FEP 5101, available from Dupont Corp, Wilmington, Del.) by first stirring the powder in a kitchen blender (Hamilton Beach Blendmaster, Wal-Mart) after the power was mixed into a “cloud”, the frame was hung into the blender for enough time for FEP to build up onto the surface of the ring. The frame, now coated with FEP powder was hung in an air convection oven (Grieve Oven, The Grieve Corporation, Round Lake, Ill.) set at 320° C. for approx. one minute followed by air cooling to room temp.
The NiTi frame was then set atop a filter sack and attached though the application of localized heat (the heat causing the FEP coating on the ring to re-melt and flow onto the surface of the filter sack, thus providing a biocompatible thermoplastic adhesive). The tether lines were then routed through a gold tube (Johnson Matthey, San Diego, Calif.) radiopaque marker. The tethers were pulled until they began to apply tension to the frame. A guidewire was then inserted into the gold band (from the opposite direction of the tether lines). The marker band was then crimped to secure the tethers and guidewire together. A small amount of instant adhesive (Loctite 401, Loctite Corp, Rocky Hill, Conn.) was applied to create a smooth transition from the guidewire to the OD of the gold band. One skilled in the art will realize that attachment of the filter to the guidewire could be accomplished by adhesion, welding, soldering, brazing, a combination of these, or a number of other methods.
Upon drying, this embodiment of the endoluminal embolic filter is ready for testing.
Various illustrative examples of the invention have been described in detail. In addition, however, many modifications and changes can be made to these examples without departing from the nature and spirit of the invention.
Cully, Edward H., Vonesh, Michael J.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4374026, | Apr 30 1980 | MAXS AG | Basket filter |
4425908, | Oct 22 1981 | NITINOL MEDICAL TECHNOLGIES, INC , 7779 WILLOW GLEN ROAD, LOS ANGELES, CA 90046, A DE CORP | Blood clot filter |
4706671, | May 02 1985 | Catheter with coiled tip | |
4723549, | Sep 18 1986 | ANGIOGUARD, INC | Method and apparatus for dilating blood vessels |
5100423, | Aug 21 1990 | Medical Engineering & Development Institute, Inc.; MED INSTITUTE MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC , A CORP OF IN | Ablation catheter |
5133733, | Nov 28 1989 | Cook Medical Technologies LLC | Collapsible filter for introduction in a blood vessel of a patient |
5192286, | Jul 26 1991 | CYSTOMEDIX, INC | Method and device for retrieving materials from body lumens |
5211651, | Aug 18 1989 | EVI Corporation | Catheter atherotome |
5495519, | Oct 04 1993 | E Lead Electronic Co., Ltd. | Control circuit for control of peripheral equipment of wireless communication appliance |
5634942, | Apr 21 1994 | B. Braun Celsa | Assembly comprising a blood filter for temporary or definitive use and a device for implanting it |
5695518, | Dec 28 1990 | Filtering device for preventing embolism and/or distension of blood vessel walls | |
5695519, | Nov 30 1995 | SUMMERS, DAVID P | Percutaneous filter for carotid angioplasty |
5709704, | Nov 30 1994 | Lifescreen Sciences LLC | Blood clot filtering |
5735892, | Aug 18 1993 | W L GORE & ASSOCIATES, INC | Intraluminal stent graft |
5769816, | Nov 07 1995 | Edwards Lifesciences Corporation | Cannula with associated filter |
5814064, | Mar 06 1997 | SciMed Life Systems, Inc. | Distal protection device |
5827324, | Mar 06 1997 | Boston Scientific Scimed, Inc | Distal protection device |
5833650, | Jun 05 1995 | KARDIAMETRICS, LLC | Catheter apparatus and method for treating occluded vessels |
5853420, | Apr 21 1994 | B. Braun Celsa | Assembly comprising a blood filter for temporary or definitive use and device for implanting it, corresponding filter and method of implanting such a filter |
5876367, | Dec 05 1996 | Edwards Lifesciences Corporation | Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries |
5893869, | Feb 19 1997 | University of Iowa Research Foundation | Retrievable inferior vena cava filter system and method for use thereof |
5902475, | Apr 08 1997 | INTERVENTIONAL TECHNOLOGIES INC , A CORPORATION OF CALIFORNIA | Method for manufacturing a stent |
5907893, | Jan 30 1996 | Medtronic Ave, Inc | Methods for the manufacture of radially expansible stents |
5910154, | May 08 1997 | Boston Scientific Scimed, Inc | Percutaneous catheter and guidewire having filter and medical device deployment |
5911734, | May 08 1997 | Boston Scientific Scimed, Inc | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
5941869, | Feb 12 1997 | PROLIFIX MEDICAL, INC | Apparatus and method for controlled removal of stenotic material from stents |
5941896, | Sep 08 1997 | Montefiore Hospital and Medical Center | Filter and method for trapping emboli during endovascular procedures |
5980552, | Mar 17 1994 | Medinol Ltd. | Articulated stent |
5980555, | Nov 07 1995 | Edwards Lifesciences Corporation | Method of using cannula with associated filter during cardiac surgery |
5989281, | Nov 07 1995 | Edwards Lifesciences Corporation | Cannula with associated filter and methods of use during cardiac surgery |
6001118, | Mar 06 1997 | Boston Scientific Scimed, Inc | Distal protection device and method |
6027520, | May 08 1997 | Boston Scientific Scimed, Inc | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
6042598, | May 08 1997 | Edwards Lifesciences Corporation | Method of protecting a patient from embolization during cardiac surgery |
6051014, | Oct 13 1998 | Edwards Lifesciences Corporation | Percutaneous filtration catheter for valve repair surgery and methods of use |
6051015, | May 08 1997 | Edwards Lifesciences Corporation | Modular filter with delivery system |
6053932, | Mar 06 1997 | Boston Scientific Scimed, Inc | Distal protection device |
6058914, | Jun 30 1997 | BRAINWORKS CO , LTD ; HOSHINO, HIROAKI | Combustion promotion auxiliary device for internal combustion engine |
6059814, | Jun 02 1997 | Medtronic Ave, Inc | Filter for filtering fluid in a bodily passageway |
6066149, | Sep 30 1997 | STRYKER EUROPEAN HOLDINGS III, LLC | Mechanical clot treatment device with distal filter |
6068645, | Jun 07 1999 | IRVINE BIOMEDICAL, INC | Filter system and methods for removing blood clots and biological material |
6074357, | Dec 05 1996 | Edwards Lifesciences Corporation | Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries |
6083215, | Jul 17 1995 | Method and apparatus for antegrade coronary perfusion | |
6090097, | May 12 1997 | Edwards Lifesciences Corporation | Aortic occluder with associated filter and methods of use during cardiac surgery |
6099549, | Jul 03 1998 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Vascular filter for controlled release |
6117154, | Nov 07 1995 | Edwards Lifesciences Corporation | Cannula with associated filter and methods of use during cardiac surgery |
6129739, | Jul 30 1999 | Incept LLC | Vascular device having one or more articulation regions and methods of use |
6136016, | Nov 07 1995 | Edwards Lifesciences Corporation | Cannula with associated filter and methods of use during cardiac surgery |
6142987, | Aug 03 1999 | Boston Scientific Scimed, Inc | Guided filter with support wire and methods of use |
6146370, | Apr 07 1999 | ZOLL CIRCULATION, INC | Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery |
6152946, | Mar 05 1998 | Boston Scientific Scimed, Inc | Distal protection device and method |
6152947, | Apr 29 1998 | Edwards Lifesciences Corporation | Adjustable blood filtration system |
6168603, | Feb 02 1995 | Boston Scientific Corporation | Surgical extractor |
6168604, | Jan 26 1998 | Advanced Cardiovascular Systems, INC | Guide wire device for removing solid objects from body canals |
6168622, | Jul 21 1998 | ST JUDE MEDICAL, CARDIOLOGY DIVISION, INC | Method and apparatus for occluding aneurysms |
6171327, | Feb 24 1999 | Boston Scientific Scimed, Inc | Intravascular filter and method |
6171328, | Nov 09 1999 | Edwards Lifesciences Corporation | Intravascular catheter filter with interlocking petal design and methods of use |
6171329, | Dec 19 1994 | W L GORE & ASSOCIATES, INC | Self-expanding defect closure device and method of making and using |
6179859, | Jul 16 1999 | Boston Scientific Scimed, Inc | Emboli filtration system and methods of use |
6187025, | Sep 09 1999 | BANK OF AMERICA, NA , AS ADMINSTRATIVE AGENT | Vascular filter |
6214025, | Nov 30 1994 | Lifescreen Sciences LLC | Self-centering, self-expanding and retrievable vena cava filter |
6224612, | Apr 23 1998 | Boston Scientific Scimed, Inc | Atraumatic medical retrieval device |
6231544, | May 14 1996 | Edwards Lifesciences Corporation | Cardioplegia balloon cannula |
6231589, | Mar 22 1999 | EV3 INC | Body vessel filter |
6235045, | Nov 07 1995 | Edwards Lifesciences Corporation | Cannula with associated filter and methods of use |
6277139, | Apr 01 1999 | Scion Cardio-Vascular, Inc. | Vascular protection and embolic material retriever |
6327772, | Jan 30 1996 | Medtronic Ave, Inc | Method for fabricating a planar eversible lattice which forms a stent when everted |
6346116, | Aug 03 1999 | Medtronic Ave, Inc | Distal protection device |
6346117, | Mar 02 2000 | PRODESCO, INC | Bag for use in the intravascular treatment of saccular aneurysms |
6361546, | Jan 13 2000 | Endotex Interventional Systems, Inc | Deployable recoverable vascular filter and methods for use |
6364895, | Oct 07 1999 | Prodesco, Inc. | Intraluminal filter |
6371969, | May 08 1997 | Boston Scientific Scimed, Inc | Distal protection device and method |
6371970, | Jul 30 1999 | Incept LLC | Vascular filter having articulation region and methods of use in the ascending aorta |
6371971, | Nov 15 1999 | Boston Scientific Scimed, Inc | Guidewire filter and methods of use |
6375670, | Oct 07 1999 | Prodesco, Inc. | Intraluminal filter |
6391037, | Mar 02 2000 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
6391044, | Feb 03 1997 | ANGIOGUARD, INC | Vascular filter system |
6432122, | Nov 07 1997 | Salviac Limited | Embolic protection device |
6485501, | Aug 11 2000 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Vascular filter system with guidewire and capture mechanism |
6511496, | Sep 12 2000 | Advanced Cardiovascular Systems, Inc. | Embolic protection device for use in interventional procedures |
6511497, | Sep 14 1999 | Cormedics GmbH | Vascular filter system |
6517559, | May 03 1999 | Blood filter and method for treating vascular disease | |
6540722, | Dec 30 1999 | Advanced Cardiovascular Systems, INC | Embolic protection devices |
6544276, | May 20 1996 | KARDIAMETRICS, LLC | Exchange method for emboli containment |
6544279, | Aug 09 2000 | Incept LLC | Vascular device for emboli, thrombus and foreign body removal and methods of use |
6558405, | Aug 29 2000 | Advanced Cardiovascular Systems, Inc. | Embolic filter |
6575996, | Jun 29 2001 | Advanced Cardiovascular Systems, INC | Filter device for embolic protection system |
6599307, | Jun 29 2001 | ABBOTT CARDIOVASCULAR SYSTEMS INC | Filter device for embolic protection systems |
6610077, | Jan 23 2001 | ABBOTT CARDIOVASCULAR SYSTEMS INC; Abbott Laboratories | Expandable emboli filter and thrombectomy device |
6635070, | May 21 2001 | Covidien LP | Apparatus and methods for capturing particulate material within blood vessels |
6660021, | Dec 23 1999 | Advanced Cardiovascular Systems, INC | Intravascular device and system |
6716231, | Aug 03 1999 | Medtronic Ave, Inc | Distal protection device |
6730117, | Mar 05 1998 | Boston Scientific Scimed, Inc | Intraluminal stent |
6890340, | Nov 29 2001 | Medtronic Vascular, Inc | Apparatus for temporary intraluminal protection |
6939361, | Sep 22 1999 | W L GORE & ASSOCIATES, INC | Guidewire for a free standing intervascular device having an integral stop mechanism |
6939362, | Nov 27 2001 | Advanced Cardiovascular Systems, INC | Offset proximal cage for embolic filtering devices |
6986778, | May 20 1996 | KARDIAMETRICS, LLC | Exchange method for emboli containment |
7214237, | Mar 12 2001 | MEMORY METAL HOLLAND BV | Vascular filter with improved strength and flexibility |
7229462, | Jul 30 1999 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Vascular filter system for carotid endarterectomy |
7229463, | Jul 30 1999 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Vascular filter system for cardiopulmonary bypass |
7241304, | Dec 21 2001 | ABBOTT CARDIOVASCULAR SYSTEMS INC | Flexible and conformable embolic filtering devices |
7306618, | Jul 30 1999 | Incept LLC | Vascular device for emboli and thrombi removal and methods of use |
7338510, | Jun 29 2001 | ABBOTT CARDIOVASCULAR SYSTEMS INC | Variable thickness embolic filtering devices and method of manufacturing the same |
7399308, | Feb 12 1999 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Vascular filter system |
8070769, | May 06 2002 | Boston Scientific Scimed, Inc | Inverted embolic protection filter |
8252017, | Oct 18 2005 | Cook Medical Technologies LLC | Invertible filter for embolic protection |
8313503, | Apr 01 2002 | W L GORE & ASSOCIATES, INC | Endoluminal devices |
8337520, | Apr 01 2002 | W L GORE & ASSOCIATES, INC | Methods of manufacture and use of endoluminal devices |
20010044634, | |||
20010044652, | |||
20020022858, | |||
20020038767, | |||
20020088531, | |||
20020091408, | |||
20020091409, | |||
20020111648, | |||
20020123720, | |||
20020138094, | |||
20030045898, | |||
20030060844, | |||
20030065354, | |||
20030065355, | |||
20030120303, | |||
20030139764, | |||
20030144688, | |||
20030153943, | |||
20030187474, | |||
20030187495, | |||
20030208224, | |||
20050177186, | |||
20050192620, | |||
20070112374, | |||
20110040314, | |||
20130144327, | |||
20130184737, | |||
EP812155, | |||
EP1566148, | |||
GB2337002, | |||
WO7521, | |||
WO16705, | |||
WO49970, | |||
WO67665, | |||
WO108595, | |||
WO119231, | |||
WO119260, | |||
WO145569, | |||
WO149215, | |||
WO3011188, | |||
WO3017823, | |||
WO3035130, | |||
WO3055412, | |||
WO3063732, | |||
WO3077799, | |||
WO9833443, | |||
WO9923976, | |||
WO9944542, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Nov 20 2012 | W. L. Gore & Associates, Inc. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Mar 11 2017 | 4 years fee payment window open |
Sep 11 2017 | 6 months grace period start (w surcharge) |
Mar 11 2018 | patent expiry (for year 4) |
Mar 11 2020 | 2 years to revive unintentionally abandoned end. (for year 4) |
Mar 11 2021 | 8 years fee payment window open |
Sep 11 2021 | 6 months grace period start (w surcharge) |
Mar 11 2022 | patent expiry (for year 8) |
Mar 11 2024 | 2 years to revive unintentionally abandoned end. (for year 8) |
Mar 11 2025 | 12 years fee payment window open |
Sep 11 2025 | 6 months grace period start (w surcharge) |
Mar 11 2026 | patent expiry (for year 12) |
Mar 11 2028 | 2 years to revive unintentionally abandoned end. (for year 12) |